Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2025-12-22 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
第十届董事会临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board resolution from the company's 10th Board of Directors' extraordinary meeting. It details the approval of a change in the company's stock short name and mentions the submission of the application to the stock exchange. The document is short (585 characters) and serves as a formal announcement of a board decision rather than a full report or detailed management information. It does not contain financial data or detailed management discussion but is clearly related to board/management information about a corporate action. Therefore, it fits best under the category 'Board/Management Information' (MANG).
2025-12-22 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter (章程) for 古汉医药集团股份公司, including comprehensive sections on company governance, shareholder rights, board structure, management, financial accounting, and other corporate rules. It references multiple shareholder meetings where amendments to the charter were approved, indicating it is a governance document. There is no indication of financial statements, earnings data, or audit results. The content is focused on internal rules, board and shareholder meeting procedures, and company structure. Therefore, this document fits the definition of a Governance Information report (CGR). The document length (15,000 characters) and detailed content confirm it is the full governance document, not just an announcement or summary.
2025-12-22 Chinese
湖南启元律师事务所关于启迪药业集团股份公司2025年第三次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and voting results of a company's 2025 third extraordinary shareholders' meeting. It details the legality and validity of the meeting's call, attendance, and voting process, referencing compliance with relevant laws and company articles. It does not contain financial statements or financial performance data, nor is it a report or announcement of financial results. The document is focused on the official voting results and legal validation of the shareholders' meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3410 characters, which is relatively short but contains detailed voting results and legal opinions on the meeting, not just an announcement of a report publication or a regulatory filing. Therefore, the best classification is DVA with high confidence.
2025-12-16 Chinese
股东会议事规则
Governance Information Classification · 100% confidence The document is titled as "股东会议事规则" which translates to "Rules of Procedure for Shareholders' Meetings" of 启迪药业集团股份公司. The content extensively details the procedures, rules, and regulations governing the convening, proposal submission, notification, conduct, voting, and resolutions of shareholders' meetings. It includes references to legal compliance, voting rights, meeting types (annual and extraordinary), and regulatory oversight. There is no financial data, earnings information, or report content. Instead, it is a governance document outlining internal rules for shareholder meetings. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-12-16 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled as "董事会议事规则" which translates to "Rules of Procedure for the Board of Directors" of 启迪药业集团股份公司. The content extensively details the structure, duties, appointment, resignation, meeting procedures, voting, and committees of the company's board of directors. It references relevant laws and regulations such as the Company Law of the People's Republic of China and Shenzhen Stock Exchange listing rules. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related internal rules document about the board's operation and management. Therefore, it fits the category of Governance Information (CGR).
2025-12-16 Chinese
2025年第三次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2025 third extraordinary shareholders meeting of 启迪药业集团股份公司. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results and decisions made by shareholders during the meeting. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is not a mere announcement of a report publication but a formal disclosure of voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2727 characters, which is consistent with a detailed voting results announcement rather than a full report.
2025-12-16 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.